dc.contributor.author |
Lao, C |
en |
dc.contributor.author |
Obertová, Z |
en |
dc.contributor.author |
Brown, C |
en |
dc.contributor.author |
Scott, Katrina |
en |
dc.contributor.author |
Edlin, Richard |
en |
dc.contributor.author |
Gilling, Peter |
en |
dc.contributor.author |
Holmes, M |
en |
dc.contributor.author |
Tyrie, L |
en |
dc.contributor.author |
Lawrenson, R |
en |
dc.date.accessioned |
2018-11-13T03:15:34Z |
en |
dc.date.issued |
2016-03 |
en |
dc.identifier.issn |
0961-5423 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/44178 |
en |
dc.description.abstract |
This study aims to examine the survival disparity between Māori men and New Zealand (NZ) Europeans diagnosed with prostate cancer. We identified men aged 40+ years in the Midland Cancer Network region registered with prostate cancer in 2007-2010 in the Cancer Registry. Data were extracted from patient notes of all Māori men and a sample of NZ Europeans. The survival disparity between Māori men and Europeans was estimated by the Kaplan-Meier method and Cox proportional-hazards regression models after adjusting for other factors. This study included 535 men with prostate cancer (135 Māori men and 400 Europeans). The 5-year cancer-specific survival was 98.6% for men diagnosed with localised cancer, 88.8% for locally advanced disease and 19.1% for metastatic cancer. The all-cause survival and the cancer-specific survival were both significantly poorer for Māori men than for NZ Europeans (log rank test: P = 0.004, 0.006 respectively). The hazard ratio of cancer-specific survival for Māori men was 2.01 (95% CI: 1.21-3.36) compared with NZ Europeans. Māori men with prostate cancer had poorer all-cause survival and cancer-specific survival than NZ Europeans. Māori men were at risk of having more advanced disease at diagnosis, which explains most of the survival inequity between Māori men and NZ Europeans. |
en |
dc.format.medium |
Print |
en |
dc.language |
eng |
en |
dc.relation.ispartofseries |
European journal of cancer care |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.subject |
Humans |
en |
dc.subject |
Prostatic Neoplasms |
en |
dc.subject |
Neoplasm Staging |
en |
dc.subject |
Proportional Hazards Models |
en |
dc.subject |
Comorbidity |
en |
dc.subject |
Adult |
en |
dc.subject |
Aged |
en |
dc.subject |
Middle Aged |
en |
dc.subject |
European Continental Ancestry Group |
en |
dc.subject |
Oceanic Ancestry Group |
en |
dc.subject |
New Zealand |
en |
dc.subject |
Male |
en |
dc.subject |
Health Status Disparities |
en |
dc.subject |
Kaplan-Meier Estimate |
en |
dc.title |
Differences in survival between Māori and New Zealand Europeans with prostate cancer. |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.1111/ecc.12468 |
en |
pubs.issue |
2 |
en |
pubs.begin-page |
262 |
en |
pubs.volume |
25 |
en |
dc.rights.holder |
Copyright: The author |
en |
dc.identifier.pmid |
26918691 |
en |
pubs.end-page |
268 |
en |
pubs.publication-status |
Published |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Research Support, Non-U.S. Gov't |
en |
pubs.subtype |
Journal Article |
en |
pubs.elements-id |
524091 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
Population Health |
en |
pubs.org-id |
Health Systems |
en |
dc.identifier.eissn |
1365-2354 |
en |
pubs.record-created-at-source-date |
2016-02-27 |
en |
pubs.dimensions-id |
26918691 |
en |